FedEx Corporation · FDX · FY2026 Q4 · Calendar Q2 2026

FedEx Caps FY2026 With Broad Beat, Raises CY2026 EPS View Post Freight Spin-Off

FedEx closed fiscal year 2026 with a decisive top- and bottom-line beat — EPS of $6.31 against $5.91 consensus and revenue of $25.0 billion versus $22.79 billion estimated — capping a transformative year. The company completed the FedEx Freight spin-off on June 1, launched FedEx Life Sciences with a temperature-controlled Ireland-to-U.S. corridor, and announced the InPost acquisition. Management introduced calendar-year guidance of CY2026 adjusted EPS of $16.90 to $18.10 (roughly 20% growth) with revenue growth of approximately 11%. Network 2.0 now routes about 45% of eligible volume through optimized stations, targeting 65% before peak season. Premium B2B verticals — healthcare, automotive, aerospace, and AI/data-center logistics — are the primary growth engine. Adjusted free cash flow reached $4.7 billion; the dividend was raised 5% and up to $1 billion in share repurchases were…

Reported After market closeNYSEIndustrials $73.96B market cap
100quality score

Company context

Snapshot as of publication

FedEx Corporation is a prominent global entity that delivers an extensive array of services encompassing transportation, e-commerce solutions, and diverse business support, catering to clients both within the United States and across international borders. Its operational structure is divided into several key segments: The FedEx Express division specializes in expedited shipping, offering rapid package and freight delivery, crucial time-sensitive logistics, and comprehensive cross-border, technological, and e-commerce transportation services. FedEx Ground focuses on reliable, scheduled delivery services for both commercial clients and individual households.…

Earnings scorecard

Reported versus consensus
Reported EPS $6.31 Consensus $6
EPS surprise +6.8% Reported versus consensus
Reported revenue $25.00B Consensus $22.79B
Revenue surprise +9.7% Reported versus consensus

Earnings History

Estimate Beat Miss Match
FDX REVENUE earnings history estimate and actual scatter chart 9 reported fiscal quarters and 4 future estimate-only quarters. Q3 '24 estimate $22B Q3 '24 actual $22B, miss Q4 '24 estimate $22B Q4 '24 actual $22B, beat Q1 '25 estimate $22B Q1 '25 actual $22B, miss Q4 '25 estimate $22B Q4 '25 actual $22B, beat Q1 '26 estimate $22B Q1 '26 actual $22B, beat Q2 '26 estimate $23B Q2 '26 actual $24B, beat Q3 '26 estimate $23B Q3 '26 actual $24B, beat Q4 '26 estimate $23B Q4 '26 actual $25B, beat Q1 '27 estimate $23B Q2 '27 estimate $24B Q3 '27 estimate $23B Q4 '27 estimate $24B
Show 1 more >

Analyst Consensus ?

ConsensusBuy47 ratings
Bullish2859.6%
Neutral1634.0%
Bearish36.4%

1 unmapped firm rating excluded from the percentages.

Analyst 52W Price Targets

$310.94Current
$155Low
$288.37Average
$479High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Truist Securities Buy BuyMaintainJun 25, 2026
UBS Buy BuyMaintainJun 24, 2026
Stifel Buy BuyMaintainJun 24, 2026
Citigroup Buy BuyMaintainJun 24, 2026
B of A Securities Buy BuyMaintainJun 24, 2026
Wells Fargo Overweight OverweightMaintainJun 17, 2026
Barclays Overweight OverweightMaintainJun 12, 2026
Morgan Stanley Underweight UnderweightMaintainJun 3, 2026
Show 40 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $310.94. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Evercore ISIAnalyst unavailable$165$329.44 -46.9%Jun 26, 2026
Truist FinancialAnalyst unavailable$365$316.83 +17.4%Jun 25, 2026
BernsteinDavid Vernon$397$315.12 +27.7%Jun 24, 2026
UBSThomas Wadewitz$350$317.24 +12.6%Jun 24, 2026
Stifel NicolausBruce Chan$326$317.24 +4.8%Jun 24, 2026
JefferiesStephanie Moore$200$328.78 -35.7%Jun 23, 2026
Stifel NicolausBruce Chan$442$330 +42.1%Jun 22, 2026
BernsteinAnalyst unavailable$424$326.2 +36.4%Jun 18, 2026
Wells FargoAnalyst unavailable$425$335.74 +36.7%Jun 17, 2026
BarclaysAnalyst unavailable$425$338 +36.7%Jun 12, 2026
See 131 more

Track every rating change on FDX the moment it posts. Free to start.

Start free

Market reaction

event-close to next-session close
Stock move -0.1% Event window
SPY move -0.0% Same window
Abnormal move -0.1% Stock minus SPY
Volume 2.9× Versus trailing sessions
Subsequent drift -0.4% Up to 20 sessions
FDXSPY benchmark

Follow FDX with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Transcript intelligence

What changed

Three structural changes define the quarter. First, the FedEx Freight spin-off was completed on June 1, 2026, positioning both entities as focused industry leaders; the prior quarter had set the schedule and arranged $3.7 billion in debt financing. Second, Network 2.0 advanced from roughly 35% to about 45% of eligible volume flowing through optimized stations, with the 65% pre-peak target reaffirmed. Third, management introduced calendar-year guidance (CY2026 adjusted EPS $16.90 to $18.10, revenue growth about 11%) alongside final fiscal-year results, replacing the prior FY2026 adjusted EPS range of $19.30 to $20.10. New initiatives include FedEx Life Sciences, the Tricolor air-freight service, and a temperature-controlled Ireland-to-U.S. health-care corridor targeting the $80 billion market. CapEx outlook shifted from decreasing to increasing.

Guidance delta

Prior quarter (Q3 FY2026): raised FY2026 adjusted EPS guidance to $19.30 to $20.10; CapEx at or below $4.1 billion (down $400 million from prior outlook); capex outlook decreasing. Current quarter (Q4 FY2026): introduced CY2026 adjusted EPS guidance of $16.90 to $18.10 (approximately 20% growth) and revenue growth of about 11% including fuel-surcharge benefit. CapEx outlook shifted to increasing. Guidance sentiment remains raised and management tone is confident. The guidance basis changed from fiscal year (ending May 2026) to calendar year 2026, so the two ranges are not directly comparable.

Key takeaways

  • FY2026 Q4 EPS of $6.31 beat consensus of $5.91 by 6.8%; revenue of $25.0 billion beat the $22.79 billion estimate by 9.7%.
  • FedEx Express revenue grew 9% year over year with 60 basis points of margin expansion — the highest in four years.
  • Network 2.0 optimization now covers about 45% of eligible volume, on track for 65% before peak season.
  • FedEx Freight spin-off completed June 1, 2026; both entities positioned as focused industry leaders.
  • Adjusted free cash flow reached $4.7 billion; dividend raised 5% and up to $1 billion in share repurchases authorized for CY2026.
  • CY2026 adjusted EPS guidance of $16.90 to $18.10 (about 20% growth) with revenue growth of about 11%.

Management priorities

  • Complete Network 2.0 rollout to 65% of eligible volume before peak season.
  • Expand the Duiven, Netherlands road hub and other European infrastructure.
  • Scale FedEx Life Sciences and temperature-controlled corridors.
  • Achieve $6 billion adjusted free cash flow by CY2029.
  • Maintain dividend growth, execute $1 billion share repurchase program, and close the InPost acquisition.

Related earnings events

Industrials

Sources

  1. Earnings call transcript and parsed analysis · 2026-06-23T23:11:31.781233+00:00
  2. FN2 earnings calendar · 2026-07-29T01:23:15.868211+00:00
  3. Polygon adjusted daily market bars · 2026-07-29T12:33:43.504968+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-29T12:33:43.501498+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.